siRNA could be a potential therapy for COVID-19

Authors

  • Sanhita Ghosh Department of Genetics and Plant Breeding, Institute of Agricultural Science, University of Calcutta, 51/2, Hazra Road, Kolkata 700073, West Bengal, India
  • Sayeed Mohammad Firdous Department of Pharmacology, Calcutta Institute of Pharmaceutical Technology & AHS, Uluberia, Howrah 711316, West Bengal, India, Mobile No. +918116427040, E-mail: firdous.cology@gmail.com
  • Anirban Nath Department of Genetics and Plant Breeding, Institute of Agricultural Science, University of Calcutta, 51/2, Hazra Road, Kolkata 700073, West Bengal, India

DOI:

https://doi.org/10.17179/excli2020-1328

Keywords:

COVID-19

Abstract

Small interfering RNA (siRNA), sometimes known as short interfering RNA or silencing
RNA, is a class of double-stranded non-coding RNA molecules, which is 20-25 base pairs in
length. siRNAs can regulate the expression of genes, by a phenomenon known as RNA interference (RNAi). Based on the phenomenon, the siRNA based therapeutics have been developed
and implemented for anticancer, antiviral, and genetic diseases.

Published

2020-04-22

How to Cite

Ghosh, S., Firdous, S. M., & Nath, A. (2020). siRNA could be a potential therapy for COVID-19. EXCLI Journal, 19, 528–531. https://doi.org/10.17179/excli2020-1328

Issue

Section

Letters to the editor